Sfoglia per Rivista ONCOTARGET
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study
2020 Aramini, Beatrice; Banchelli, Federico; Bettelli, Stefania Raffaella; Manfredini, Samantha; D'Amico, Roberto; Masciale, Valentina; Pinelli, Massimo; MORETTI FANTERA, Margherita; Stefani, Alessandro; Bertolini, Federica; Dominici, Massimo; Morandi, Uliano; Maiorana, Antonino
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients
2010 Martelli, ALBERTO MARIA; Evangelisti, Camilla; Chiarini, Francesca; J. A., Mccubrey
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors
2015 Lonetti, A; Cappellini, A; Spartà, Am; Chiarini, F; Buontempo, F; Evangelisti, C; Evangelisti, C; Orsini, E; Mccubrey, Ja; Martelli, Am
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy
2016 Berardi, Rossana; Rinaldi, Silvia; Santoni, Matteo; Newsom Davis, Thomas; Tiberi, Michela; Morgese, Francesca; Caramanti, Miriam; Savini, Agnese; Ferrini, Consuelo; Torniai, Mariangela; Fiordoliva, Ilaria; Bower, Marc; Cascinu, Stefano
Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: Results from the ITACa trial
2016 Casadei Gardini, Andrea; Carloni, Silvia; Scarpi, Emanuela; Maltoni, Paolo; Dorizzi, Romolo M.; Passardi, Alessandro; Frassineti, Giovanni Luca; Cortesi, Pietro; Giannini, Maria Benedetta; Marisi, Giorgia; Amadori, Dino; Lucchesi, Alessandro
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
2012 Mccubrey, Ja; Steelman, Ls; Chappell, Wh; Abrams, Sl; Franklin, Ra; Montalto, G; Cervello, M; Libra, M; Candido, S; Malaponte, G; Mazzarino, Mc; Fagone, P; Nicoleti, F; Bäsecke, J; Mijatovic, S; Maksimovic-Ivanic, D; Milella, M; Tafuri, A; Chiarini, F; Evangelisti, C; Cocco, L; Martelli, Am.
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress
2016 Conforti, Antonella; Starc, Nadia; Biagini, Simone; Tomao, Luigi; Pitisci, Angela; Algeri, Mattia; Sirleto, Pietro; Novelli, Antonio; Grisendi, Giulia; Candini, Olivia; Carella, Cintia; Dominici, Massimo; Locatelli, Franco; Bernardo, Maria Ester
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience.
2017 Vici, P; Pizzuti, L; Michelotti, A; Sperduti, I; Natoli, C; Mentuccia, L; Di Lauro, L; Sergi, D; Marchetti, P; Santini, D; Magnolfi, E; Iezzi, L; Moscetti, L; Fabbri, A; Cassano, A; Grassadonia, A; Omarini, Claudia; Piacentini, Federico; Botticelli, A; Bertolini, I; Scinto, Af; Zampa, G; Mauri, M; D'Onofrio, L; Sini, V; Barba, M; Maugeri Saccà, M; Rossi, E; Landucci, E; Tomao, S; Alberti, Am; Giotta, F; Ficorella, C; Adamo, V; Russo, A; Lorusso, V; Cannita, K; Barni, S; Laudadio, L; Greco, F; Garrone, O; Giulia, Md; Marolla, P; Sanguineti, G; Di Cocco, B; Ciliberto, G; De Maria, R; Gamucci, T.
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling
2016 Mediani, Laura; Gibellini, Federica; Bertacchini, Jessika; Frasson, Chiara; Bosco, Raffaella; Accordi, Benedetta; Basso, Giuseppe; Bonora, Massimo; Calabrò, Maria Luisa; Mattiolo, Adriana; Sgarbi, Gianluca; Baracca, Alessandra; Pinton, Paolo; Riva, Giovanni; Rampazzo, Enrico; Petrizza, Luca; Prodi, Luca; Milani, Daniela; Luppi, Mario; Potenza, Leonardo; De Pol, Anto; Cocco, Lucio; Capitani, Silvano; Marmiroli, Sandra
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells
2014 Bonuccelli, Gloria; Avnet, Sofia; Grisendi, Giulia; Salerno, Manuela; Granchi, Donatella; Dominici, Massimo; Kusuzaki, Katsuyuki; Baldini, Nicola
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit
2020 Chae, H. -D.; Dutta, R.; Tiu, B.; Hoff, F. W.; Accordi, B.; Serafin, V.; Youn, M.; Huang, M.; Sumarsono, N.; Davis, K. L.; Lacayo, N. J.; Pigazzi, M.; Horton, T. M.; Kornblau, S. M.; Sakamoto, K. M.
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases
2017 Civallero, Monica; Cosenza, Maria; Pozzi, Samantha; Sacchi, Stefano
The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells
2017 Piccolella, Margherita; Crippa, Valeria; Cristofani, Riccardo; Rusmini, Paola; Galbiati, Mariarita; Cicardi, Maria Elena; Meroni, Marco; Ferri, Nicola; Morelli, FEDERICA FRANCESCA; Carra, Serena; Messi, Elio; Poletti, Angelo
Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer
2015 Barbier Torres, Lucía; Delgado, Teresa C; García Rodríguez, Juan L; Zubiete Franco, Imanol; Fernández Ramos, David; Buqué, Xabier; Cano, Ainara; Gutiérrez de Juan, Virginia; Fernández Domínguez, Itziar; Lopitz Otsoa, Fernando; Fernández Tussy, Pablo; Boix, Loreto; Bruix, Jordi; Villa, Erica; Castro, Azucena; Lu, Shelly C; Aspichueta, Patricia; Xirodimas, Dimitris; Varela Rey, Marta; Mato, José M; Beraza, Naiara; Martínez Chantar, María L.
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: Turning offthe prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NF-κB
2016 Buontempo, Francesca; Orsini, Ester; Lonetti, Annalisa; Cappellini, Alessandra; Chiarini, Francesca; Evangelisti, Camilla; Evangelisti, Cecilia; Melchionda, Fraia; Pession, Andrea; Bertaina, Alice; Locatelli, Franco; Bertacchini, Jessika; Neri, Luca Maria; Mccubrey, James A.; Martelli, Alberto Maria
Targeting the STAT5 pathway in Ph+ acute lymphoblastic leukemia
2018 Minieri, Valentina; De Dominici, Marco; Nevalainen, Marja T; Calabretta, Bruno
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma
2017 Petrachi, Tiziana; Romagnani, Alessandra; Albini, Adriana; Longo, Caterina; Argenziano, Giuseppe; Grisendi, Giulia; Dominici, Massimo; Ciarrocchi, Alessia; Dallaglio, Katiuscia
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment
2012 Martelli, Am; Chiarini, F; Evangelisti, C; Cappellini, A; Buontempo, F; Bressanin, D; Fini, M; Mccubrey, Ja.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study | 1-gen-2020 | Aramini, Beatrice; Banchelli, Federico; Bettelli, Stefania Raffaella; Manfredini, Samantha; D'Amico, Roberto; Masciale, Valentina; Pinelli, Massimo; MORETTI FANTERA, Margherita; Stefani, Alessandro; Bertolini, Federica; Dominici, Massimo; Morandi, Uliano; Maiorana, Antonino | |
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients | 1-gen-2010 | Martelli, ALBERTO MARIA; Evangelisti, Camilla; Chiarini, Francesca; J. A., Mccubrey | |
PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors | 1-gen-2015 | Lonetti, A; Cappellini, A; Spartà, Am; Chiarini, F; Buontempo, F; Evangelisti, C; Evangelisti, C; Orsini, E; Mccubrey, Ja; Martelli, Am | |
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy | 1-gen-2016 | Berardi, Rossana; Rinaldi, Silvia; Santoni, Matteo; Newsom Davis, Thomas; Tiberi, Michela; Morgese, Francesca; Caramanti, Miriam; Savini, Agnese; Ferrini, Consuelo; Torniai, Mariangela; Fiordoliva, Ilaria; Bower, Marc; Cascinu, Stefano | |
Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: Results from the ITACa trial | 1-gen-2016 | Casadei Gardini, Andrea; Carloni, Silvia; Scarpi, Emanuela; Maltoni, Paolo; Dorizzi, Romolo M.; Passardi, Alessandro; Frassineti, Giovanni Luca; Cortesi, Pietro; Giannini, Maria Benedetta; Marisi, Giorgia; Amadori, Dino; Lucchesi, Alessandro | |
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance | 1-gen-2012 | Mccubrey, Ja; Steelman, Ls; Chappell, Wh; Abrams, Sl; Franklin, Ra; Montalto, G; Cervello, M; Libra, M; Candido, S; Malaponte, G; Mazzarino, Mc; Fagone, P; Nicoleti, F; Bäsecke, J; Mijatovic, S; Maksimovic-Ivanic, D; Milella, M; Tafuri, A; Chiarini, F; Evangelisti, C; Cocco, L; Martelli, Am. | |
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress | 1-gen-2016 | Conforti, Antonella; Starc, Nadia; Biagini, Simone; Tomao, Luigi; Pitisci, Angela; Algeri, Mattia; Sirleto, Pietro; Novelli, Antonio; Grisendi, Giulia; Candini, Olivia; Carella, Cintia; Dominici, Massimo; Locatelli, Franco; Bernardo, Maria Ester | |
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real-world experience. | 1-gen-2017 | Vici, P; Pizzuti, L; Michelotti, A; Sperduti, I; Natoli, C; Mentuccia, L; Di Lauro, L; Sergi, D; Marchetti, P; Santini, D; Magnolfi, E; Iezzi, L; Moscetti, L; Fabbri, A; Cassano, A; Grassadonia, A; Omarini, Claudia; Piacentini, Federico; Botticelli, A; Bertolini, I; Scinto, Af; Zampa, G; Mauri, M; D'Onofrio, L; Sini, V; Barba, M; Maugeri Saccà, M; Rossi, E; Landucci, E; Tomao, S; Alberti, Am; Giotta, F; Ficorella, C; Adamo, V; Russo, A; Lorusso, V; Cannita, K; Barni, S; Laudadio, L; Greco, F; Garrone, O; Giulia, Md; Marolla, P; Sanguineti, G; Di Cocco, B; Ciliberto, G; De Maria, R; Gamucci, T. | |
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling | 1-gen-2016 | Mediani, Laura; Gibellini, Federica; Bertacchini, Jessika; Frasson, Chiara; Bosco, Raffaella; Accordi, Benedetta; Basso, Giuseppe; Bonora, Massimo; Calabrò, Maria Luisa; Mattiolo, Adriana; Sgarbi, Gianluca; Baracca, Alessandra; Pinton, Paolo; Riva, Giovanni; Rampazzo, Enrico; Petrizza, Luca; Prodi, Luca; Milani, Daniela; Luppi, Mario; Potenza, Leonardo; De Pol, Anto; Cocco, Lucio; Capitani, Silvano; Marmiroli, Sandra | |
Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells | 1-gen-2014 | Bonuccelli, Gloria; Avnet, Sofia; Grisendi, Giulia; Salerno, Manuela; Granchi, Donatella; Dominici, Massimo; Kusuzaki, Katsuyuki; Baldini, Nicola | |
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit | 1-gen-2020 | Chae, H. -D.; Dutta, R.; Tiu, B.; Hoff, F. W.; Accordi, B.; Serafin, V.; Youn, M.; Huang, M.; Sumarsono, N.; Davis, K. L.; Lacayo, N. J.; Pigazzi, M.; Horton, T. M.; Kornblau, S. M.; Sakamoto, K. M. | |
Ruxolitinib combined with vorinostat suppresses tumor growth and alters metabolic phenotype in hematological diseases | 1-gen-2017 | Civallero, Monica; Cosenza, Maria; Pozzi, Samantha; Sacchi, Stefano | |
The small heat shock protein B8 (HSPB8) modulates proliferation and migration of breast cancer cells | 1-gen-2017 | Piccolella, Margherita; Crippa, Valeria; Cristofani, Riccardo; Rusmini, Paola; Galbiati, Mariarita; Cicardi, Maria Elena; Meroni, Marco; Ferri, Nicola; Morelli, FEDERICA FRANCESCA; Carra, Serena; Messi, Elio; Poletti, Angelo | |
Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer | 1-gen-2015 | Barbier Torres, Lucía; Delgado, Teresa C; García Rodríguez, Juan L; Zubiete Franco, Imanol; Fernández Ramos, David; Buqué, Xabier; Cano, Ainara; Gutiérrez de Juan, Virginia; Fernández Domínguez, Itziar; Lopitz Otsoa, Fernando; Fernández Tussy, Pablo; Boix, Loreto; Bruix, Jordi; Villa, Erica; Castro, Azucena; Lu, Shelly C; Aspichueta, Patricia; Xirodimas, Dimitris; Varela Rey, Marta; Mato, José M; Beraza, Naiara; Martínez Chantar, María L. | |
Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: Turning offthe prosurvival ER chaperone BIP/Grp78 and turning on the proapoptotic NF-κB | 1-gen-2016 | Buontempo, Francesca; Orsini, Ester; Lonetti, Annalisa; Cappellini, Alessandra; Chiarini, Francesca; Evangelisti, Camilla; Evangelisti, Cecilia; Melchionda, Fraia; Pession, Andrea; Bertaina, Alice; Locatelli, Franco; Bertacchini, Jessika; Neri, Luca Maria; Mccubrey, James A.; Martelli, Alberto Maria | |
Targeting the STAT5 pathway in Ph+ acute lymphoblastic leukemia | 1-gen-2018 | Minieri, Valentina; De Dominici, Marco; Nevalainen, Marja T; Calabretta, Bruno | |
Therapeutic potential of the metabolic modulator phenformin in targeting the stem cell compartment in melanoma | 1-gen-2017 | Petrachi, Tiziana; Romagnani, Alessandra; Albini, Adriana; Longo, Caterina; Argenziano, Giuseppe; Grisendi, Giulia; Dominici, Massimo; Ciarrocchi, Alessia; Dallaglio, Katiuscia | |
Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment | 1-gen-2012 | Martelli, Am; Chiarini, F; Evangelisti, C; Cappellini, A; Buontempo, F; Bressanin, D; Fini, M; Mccubrey, Ja. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile